Approval · Notice of Compliance 6713 · 1998
DECTOMAX INJECTABLE SOLUTION: Notice of Compliance 6713
Issued February 4, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6713
- Date
- February 4, 1998
- Company
- Pfizer Canada Inc., Animal Health GroupKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional claims
- Therapeutic class
- Antiparasitic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DECTOMAX INJECTABLE SOLUTION | 02231083 | Marketed |
Medicinal ingredients
- DORAMECTIN 10 MG per ML